Taysha Gene Therapies, Inc.
TSHA
$4.06
-$0.37-8.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 88.56% | 81.06% | -5.96% | -3.41% | -4.01% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -56.90% | -48.92% | 45.66% | 24.41% | 8.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -9.81% | -36.78% | -60.56% | -64.15% | -65.57% |
| Total Current Assets | 85.66% | 77.21% | -7.57% | -5.16% | -5.97% |
|
|
|||||
| Total Current Assets | 85.66% | 77.21% | -7.57% | -5.16% | -5.97% |
| Net Property, Plant & Equipment | -12.42% | -24.40% | -23.22% | -22.26% | -22.50% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.52% | -4.18% | -4.73% | -3.54% | -19.38% |
| Total Assets | 75.65% | 66.34% | -9.57% | -7.16% | -7.94% |
|
|
|||||
| Total Accounts Payable | 10.26% | -11.53% | -58.32% | -43.58% | -34.41% |
| Total Accrued Expenses | 53.15% | 2.93% | -24.12% | 1.34% | -17.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -8.10% | -0.91% | 6.60% | 14.03% | 18.01% |
| Total Finance Division Other Current Liabilities | -45.91% | -53.90% | -47.06% | -42.07% | -91.76% |
| Total Other Current Liabilities | -45.91% | -53.90% | -47.06% | -42.07% | -91.76% |
| Total Current Liabilities | -2.40% | -25.83% | -41.62% | -28.65% | -83.74% |
|
|
|||||
| Total Current Liabilities | -2.40% | -25.83% | -41.62% | -28.65% | -83.74% |
| Long-Term Debt | 18.34% | 8.50% | 4.79% | 8.48% | 11.47% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.15% | -9.29% | -9.42% | -6.40% | -8.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 72.22% | 53.63% | 11.99% | -41.03% | -85.17% |
| Total Liabilities | 6.72% | -7.56% | -15.98% | -9.16% | -62.67% |
|
|
|||||
| Common Stock & APIC | 33.93% | 35.47% | 15.23% | 15.29% | 31.86% |
| Retained Earnings | -17.13% | -16.62% | -16.16% | -17.41% | -4.06% |
| Treasury Stock & Other | 50.90% | -129.06% | -810.76% | -- | -- |
| Total Common Equity | 146.62% | 128.47% | 2.25% | -4.55% | 280.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 146.62% | 128.47% | 2.25% | -4.55% | 280.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 146.62% | 128.47% | 2.25% | -4.55% | 280.80% |
|
|
|||||